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1. Introduction 
T4, the main secretory product of the thyroid 
gland, is deiodinated and conjugated in peripheral tis- 
sues [ 1,2]. Phenolic ring deiodination of T4 accounts 
for -80% of the total body production of Ts, the 
most biologically active iodothyronine [3]. The 
remainder is produced by the thyroid gland. The 
other main product of peripheral deiodination is rT3, 
which is biologically inactive [4]. Initiation of biolog- 
ical activity by Ts occurs after binding to nuclear 
receptors [5]. At least 70% of the liver nuclear bound 
Ts is derived from the extracellular compartment and 
the remainder from local, intracellular deiodination 
of T4 [6]. The liver, which contains -30% of the total 
T4 pool and 80% of all intracellularly located T4, is an 
important organ for the production of thyroid hor- 
mone metabolites [7]. Studies related to membranal 
transport of iodothyronines into hepatic cells are 
important since they may increase our understanding 
of regulatory mechanisms involved in the ultimate 
delivery of thyroid hormone to intracellular active 
sites like metabolizing enzymes and receptors. 
fluorescent T3 in cultured iibroblasts [14,15]. We 
report here on a difference in ATPdependency of the 
uptake of T3 on the one hand and that of T4 and rTa 
on the other by rat hepatocytes in primary culture. 
T4 and rTa showed the most remarkable diminution 
of transport by small decreases in cellular ATP content. 
In addition, effects of propranolol, X-ray contrast 
agents, amiodarone and cytoskeleton-disrupting 
agents have been studied. The results indicate that 
besides changes in T4 deiodination [ 1,2] and sulfo- 
conjugation [ 16,171, decrease in cellular uptake of T4 
by tissues secondary to decreased cellular ATP con- 
centrations or to the effects of some compounds may 
be a contributing factor to the clinical condition 
known as low T3 syndrome. A preliminary account of 
this work has been published [ 181. 
2. Materials and methods 
Uptake of T3 and T4 by rat hepatocytes in primary 
culture is mediated by distinct, ATPdependent pro- 
cesses [S]. Additionally, they are saturably bound to 
the surface of the plasma membrane [8-IO]. Study of 
the binding of T3 and T4 to purified rat liver plasma 
membranes has revealed 2 sets of saturable sites for 
both hormones of which the highest affinity compo- 
nents do not seem to reflect a common binding site 
[ 11-131. In harmony with the concept of an active 
transport mechanism for the uptake of thyroid hor- 
mone by cells is the visualization by video intensifica- 
tion microscopy of receptor-mediated endocytosis of 
The sources of most materials are mentioned in 
[8,9]. The purity of tri-[3,3’,-5’-‘251]iodothyronine 
(The Radiochemical Centre, Amersham), spec. act. 
>1200 E.tCi/pg, was verified by HPLC [ 191. The fol- 
lowing drugs were generous gifts; sodium ipodate 
(Schering, Berlin), sodium tyropanoate and iopanoic 
acid (Sterling-Winthrop Labs, NY), D- and L-propran- 
0101 (ICI, Rotterdam) and amiodarone (La Baz, 
Maassluis). Inhibitors of the cytoskeleton (vinblastine, 
colchicine, cytochalasine B) were purchased from 
Sigma (St Louis MO). 
The experimental details of isolation (collagenase 
perfusion technique), culture and incubations of rat 
hepatocytes with thyroid hormone are in [8]. Uptake 
was studied in rat hepatocytes in monolayer culture 
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(2 X lo6 cells/dish) and were performed in quadrupli- 
cate/expt by incubations for 1 min at 37°C with ‘*‘I- 
labelled thyroid hormone and additional amounts of 
unlabelled hormone in 4 ml incubation medium [8] 
containing 1% (for uptake of T3 and rT3) or 0.5% 
(T4) bovine serum albumin. In some experiments, 
uptake studies were preceded by incubations in incu- 
bation medium for 30 min with various concentra- 
tions of glucose or fructose to decrease the cellular 
ATP content [20], 1 and 10 PM propranolol, 11 /.LM 
vinblastine, 25 PM colchicine or 25 PM cytochalasin B. 
In other experiments uptake was studied in the pres- 
ence of iopanoic acid, sodium tyropanoate, sodium 
ipodate (10 and 100 PM) or amiodarone (1 PM). 
The procedure of calculation of transport was 
based on the principle of the mutual inhibition by 
substrates for their energy-dependent uptake systems 
as in [8]. Unpublished observations (E. P. K., R. D., 
H. F. B.) showed transport of reverse T3 with K, 
6 nM at 37”C, which can be inhibited by T3. To paral- 
lel uptake studies of Tq, T3 and rTj the following free 
amounts of iodothyronines were added to inhibit 
transport of the particular iodothyronine (in paren- 
theses): 6.8 PM T3 (T4); 0.8 E.~M T4 (T3); and 2.9 PM 
T3 (rT3). The difference in total uptake and uptake in 
the parallel incubation yields a measure of the active 
transport. Measurements of free hormone concentra- 
tions and ATP content was done as in [8]. 
3. Results 
3 .l . Effect of changes in A TP content on Tik T3 and 
rT, transport 
Monolayers of hepatocytes were preincubated for 
30 min with different concentrations of glucose or 
fructose to vary the ATP content of the liver cells 
(fig.1). A curvilinear relationship is found between 
transport of T4 or rT, and ATP, in contrast to a linear 
correlation with T3. This transport was studied with 
hormone concentrations which are below the K, of 
the transport system of the particular iodothyronine 
([ 81, this paper) to study transport in the absence of 
saturation of the uptake mechanism. The interrela- 
tionships between T, and T, transport and between 
T4 and rT3 transport are shown in fig.2. In fig.2 the 
ratios of the percentage of inhibition of T4 transport 
relative to that of T3 or rT3 are calculated and related 
to the ATP content. For instance, with a preincuba- 
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Fig.1. Active transport (in % of control) of iodothyronines 
into rat hepatocytes in primary culture as function of cellular 
ATP content (in % of control). Values from incubations with 
6.7 mM glucose are expressed as 100%. The absolute control 
values amounted to 0.67 T,, 36 T, and 3.8 IT, pmol . 35 pg 
DNA-I . min-’ and 64 nmol ATP/35 pg DNA. ATP content 
was varied by pre-exposure of the cells to the indicated con- 
centrations of glucose or fructose. Thereafter the monolayers 
were exposed to the following free hormone levels for 1 min 
at 37°C: 0.1 nM T,, 9 nM T, and 1.2 nM IT,. Each uptake 
value represents the mean f SEM of >6 expt (in quadrupli- 
cate) and ATP values are from >I6 expt (at least in duplicate). 
Statistical evaluation of T, and T, transport with Student’s 
t-test results in: ‘p < 0.005; * p < 0.025; ‘p = 0.025. 
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Fig.2. Ratios of the amount of inhibition of T,-T, transport 
and T,-rT, transport as function of cellular ATP content. 
Data are taken from fig.1. 
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tion with 4 mM glucose, the fall in ATP content com- 
pared to control is 20%. This resulted in +-times 
more inhibition of T4 transport than of T3 (ratio is 5) 
whereas the inhibition of T4 and rTJ transport is 
about equal (ratio is 1.2, which value does not change 
with lower ATP levels). Thus, it seems that T4 and 
rTa transport are in a similar way dependent on ATP 
concentration in contrast to T3 transport and it is the 
small decrease in cellular ATP content, that results in 
a greater inhibition of T4 and rTs transport compared 
to T3. 
3.2. Effects of structurally related compounds on T4 
and T3 transport 
Uptake of thyroid hormone in the presence of 10 
or 100 PM sodium ipodate, sodium tyropanoate, 
iopanoic acid or 1 PM amiodarone results in a statis- 
tically significant decrease in transport of T3 and T4 
(table 1). A lower concentration of bovine serum 
albumin in the incubation medium is used for T4 
uptake studies to increase the percentage uptake, as 
the free fraction of T4 is much lower compared to T3 
or rT,. This may have implications for the free 
amounts (not tested) of the above compounds, and 
therefore comparison of the decreases in TJ and T4 
transport by these compounds in this experiment is 
not opportune. 
3.3. Effects of D- and L-propranolol and inhibitors of 
thecytoskeleton function on T3 and T4 transport 
Pretreatment of monolayers for 30 min with vin- 
blastine, colchicine or cytochalasin B leads to a dimin- 
ished transport of T3 and T4 (table 1). Similarly, the 
isomers of propranolol show this effect (table 1). 
These agents are able to decrease the cellular ATP con- 
tent markedly (table 1). When similar ATP-decreases 
were compared between the experiments as illustrated 
in fig.1 and table 1 no significant differences in inhibi- 
tion of T4 transport were present. However, T3 trans- 
port is significantly more diminished (one way analy- 
sis of variance, [2 I], all p levels CO.025) in the experi- 
ments from table 1. 
Table 1 
Effect of preincubation for 30 min with D, L-propranolol, vinblastine, colchicine and cytochalasin B and of 
incubation for 1 min with sodium tyropanoate, sodium ipodate, iopanoic acid and amiodarone on the 
active transport of T, and T, into rat hepatocytes in primary culture 
Agent /JM T, 
%control (n) SEM 
TX 
% control (n) SEM 
ATP 
%control (n) SEM 
Sodium tyropanoate 10 51 
Sodium tyropanoate 100 19 
Iopanoic acid 10 58 
lopanoic acid 100 22 
Sodium ipodate 10 49 
Sodium ipodate 100 32 
Amiodarone 1 20 
Vinblastine 11 26 
Colchicine 25 14 
Cytochalasin 25 17 
DPropranolol 1 43 
DPropranolol 10 19 
L-Propranolol 1 44 
LPropranolol 10 21 
(5) 8a 53 
(5) 13a 39 
(5) llb 57 
(5) 14a 44 
(5) 9a 53 
(4) 1oa 45 
(3) 9a 31 
(3) 13a 45 
(3) 2a 34 
(3) 2a 23 
(6) 7a 45 
(6) 7a7c 23 
(6) 7a 53 
(6) 4a 30 
(4) 
(6) 
(3) 
(5) 
(3) 
(5) 
(3) 
(4) 
(5) 
(4) 
(4) 
(7) 
(4) 
(5) 
21a 
11a 
10a 
14a 
13a 
4a 
8a 
7a 
5a 
9a 
8a 
6a,d 
13a 
7a,e 
n.s. 
n.s. 
n.s. 
n.s. 
43 (4) 5 
37 (4) 8 
37 (4) 7 
42 (3) 5 
41 (4) 6 
45 (3) 12 
39 (4) 8 
a,b p-Values for difference with control (a p < 0.001, b p < 0.005) 
cpd Difference with 1 PM D-isomer (‘p < 0.05; d p < 0.001) 
e Difference with 1 PM L-isomer (e p < 0.01); n.s., not significant 
The free hormone concentrations used are mentioned in fig.1, and are below the Km of the transport system. 
Statistical evaluation was performed according to the one way analysis of variance [ 211. n, no. expt (in qua- 
druplicate) 
231 
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4. Discussion 
By kinetic analysis of their mututal inhibition of 
transport, active transport of T3 and T4 were shown 
to take place via different pathways [8]. According 
to these results, the ATP dependency of these trans- 
port mechanisms is different, such that small decreases 
in ATP content result in a larger inhibition of T4 trans- 
port and after a certain amount of decrease in ATP, 
T4 transport becomes ATP-independent. Unpublished 
observations (E. P. K., R. D., H. F. B.) have shown 
that similarly to T4 [8] and T3 [9], rTj is taken up by 
a high affinity system (Km -6 nM), which is energy- 
dependent (this study). Transport of T4 and rT, are 
in a similar way dependent on ATP, which might indi- 
cate that T4 and rTs share a common transport path- 
way. Apparently, in addition to the intracellularly 
located deiodinase activity [ 1,2] and conjugating 
enzymes [ 16 ,171, rat hepatocytes in primary culture 
are able to regulate the peripheral metabolism of iodo- 
thyronines by influencing the rate of their entry. 
Diminished entry of T4 and rTg by a lowered ATP 
content in (patho-)physiological conditions results in 
decreased production of T3 and degradation of rT3, 
respectively. In concert with a diminished activity of 
the 5’-deiodinase activity in various conditions [22], 
these differences in transport can play a role in the 
genesis of the alterations of serum iodothyronine con- 
centrations in the low T3 syndrome. In T4 perfusion 
of livers from fasted rats, T4 uptake was diminished 
up to 40% [23]. Many compounds [24] (e.g., X-ray 
contrast agents, propranolol, amiodarone) can induce 
a low Ts syndrome, which has been explained by 
inhibition of the activity of 5’-deiodinase. However, 
50% inhibition of this activity in isolated hepatocytes 
[25] or homogenates [26] has been achieved with 
-500 PM D,L-propranolol, -3 orders of magnitude 
higher than in vivo plasma levels of subjects given the 
usual therapeutic dosage [27]. Furthermore, a mem- 
brane-stabilizing effect seems to be achieved with con- 
centrations of propranolol, which are -1 order of mag- 
nitude higher than the usual therapeutic plasma level 
[27]. This makes it less probable that the observed 
effect of therapeutic amounts of D-propranolol (which 
is devoid of P-blocking activity) on T3 formation from 
T4 in T4 substituted subjects is merely by this mem- 
brane stabilizing action, as suggested in [ 28,291. This 
suggestion was based on the fact that quinidine inhib- 
ited the formation of T3 in a similar way. The ATP- 
lowering effect of local anaesthetics (including quini- 
232 
dine) is described in [30]. Pretreatment of monolayers 
of hepatocytes with D- and Lpropranolol in the ther- 
apeutic concentration range, results in a marked 
lowering of the ATP content and in an inhibition of 
T4 and T3 entry by 250%. Consequently, at first 
sight it seems that the common denominator of the 
observed similar effects of both isomers is diminished 
active transport of iodothyronine by reduced ATP 
levels. However, at similar ATP levels, inhibition of 
T3 transport by propranolol is more pronounced as 
compared to control. The reason for this finding is 
unclear. 
Similarly, X-ray contrast agents and amiodarone 
added to the incubation medium with T4 or T3 lead 
to a decreased uptake in our system. Because of the 
structural similarities between these compounds and 
thyroid hormone, their effect can be explained by 
competitive inhibition of uptake, as has been shown 
for T4 conversion [26]. 
X-Ray contrast agents are able to inhibit uptake of 
T4 and T3 by rat liver slices [31]. In vivo, sodium 
tyropanoate can displace T4 from the liver [32] and 
provoke an acute increase in serum T4 [33]. In addi- 
tion to displacement from liver cytosol binding pro- 
teins, competitive inhibition of inward transport of 
T4 through the plasma membrane may be another 
effect of tyropanoate [32]. 
In many plasma-membrane processes, like carrier- 
mediated transport, the cytoskeleton plays an essential 
role, and can be perturbed by agents like colchicine, 
vinblastine and cytochalasin B. In our system these 
agents decreased thyroid hormone transport too, sug- 
gesting a direct relation of the uptake mechanism and 
the cytoskeleton. However, these compounds 
decreased the ATP content as well, which in part may 
also explain our findings. Both effects are in agree- 
ment with [ 14,151, that the mechanism by which 
thyroid hormone is taken up is endocytosis, which is 
an energy-cytoskeleton-dependent (and time-con- 
suming) process [34]. 
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